• Login
    View Item 
    •   Home
    • The Manchester Institute Cancer Research UK
    • All Paterson Institute for Cancer Research
    • View Item
    •   Home
    • The Manchester Institute Cancer Research UK
    • All Paterson Institute for Cancer Research
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Towards hematopoietic stem cell-mediated protection against infection with human immunodeficiency virus.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Schambach, Axel
    Schiedlmeier, B
    Kühlcke, K
    Verstegen, M
    Margison, Geoffrey P
    Li, Z
    Kamino, K
    Bohne, J
    Alexandrov, A
    Hermann, F G
    Von Laer, D
    Baum, Christopher
    Show allShow less
    Affiliation
    Department of Hematology, Hemostaseology and Oncology, Hannover Medical School, Hannover, Germany.
    Issue Date
    2006-07
    
    Metadata
    Show full item record
    Abstract
    The failure of pharmacological approaches to cure infection with the human immunodeficiency virus (HIV) has renewed the interest in gene-based therapies. Among the various strategies that are currently explored, the blockade of HIV entry into susceptible T cells and macrophages promises to be the most powerful intervention. For long-term protection of both of these lineages, genetic modification of hematopoietic stem cells (HSCs) would be required. Here, we tested whether HSCs and their progeny can be modified to express therapeutic levels of M87o, a gammaretroviral vector encoding an artificial transmembrane molecule that blocks fusion-mediated uptake of HIV. In serial murine bone marrow transplantations, efficient and multilineage expression of M87o was observed for more than 1 year (range 37-75% of mononuclear cells), without signs of toxicity related to the transmembrane molecule. To allow enrichment of M87o-modified HSCs after transplant, we constructed vectors coexpressing the P140K mutant of O(6)-methylguanine-DNA-methyltransferase (MGMT-P140K). This clinically relevant selection marker mediates a survival advantage in HSCs if exposed to combinations of methylguanine-methyltransferase (MGMT) inhibitors and alkylating agents. A bicistronic vector mediated sufficient expression of both M87o and MGMT to confer a selective survival advantage in the presence of HIV and alkylating agents, respectively. These data encourage further investigations in large animal models and clinical trials.
    Citation
    Towards hematopoietic stem cell-mediated protection against infection with human immunodeficiency virus. 2006, 13 (13):1037-47 Gene Ther.
    Journal
    Gene Therapy
    URI
    http://hdl.handle.net/10541/72685
    DOI
    10.1038/sj.gt.3302755
    PubMed ID
    16541120
    Type
    Article
    Language
    en
    ISSN
    0969-7128
    ae974a485f413a2113503eed53cd6c53
    10.1038/sj.gt.3302755
    Scopus Count
    Collections
    All Paterson Institute for Cancer Research

    entitlement

    Related articles

    • Hematoprotection and enrichment of transduced cells in vivo after gene transfer of MGMT(P140K) into hematopoietic stem cells.
    • Authors: Jansen M, Sorg UR, Ragg S, Flasshove M, Seeber S, Williams DA, Moritz T
    • Issue date: 2002 Sep
    • Characterisation of a P140K mutant O6-methylguanine-DNA-methyltransferase (MGMT)-expressing transgenic mouse line with drug-selectable bone marrow.
    • Authors: Kramer BA, Lemckert FA, Alexander IE, Gunning PW, McCowage GB
    • Issue date: 2006 Sep
    • Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.
    • Authors: Schambach A, Bohne J, Chandra S, Will E, Margison GP, Williams DA, Baum C
    • Issue date: 2006 Feb
    • Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities.
    • Authors: Sakurai F, Kawabata K, Yamaguchi T, Hayakawa T, Mizuguchi H
    • Issue date: 2005 Oct
    • Comparison of HIV- and EIAV-based vectors on their efficiency in transducing murine and human hematopoietic repopulating cells.
    • Authors: Siapati EK, Bigger BW, Miskin J, Chipchase D, Parsley KL, Mitrophanous K, Themis M, Thrasher AJ, Bonnet D
    • Issue date: 2005 Sep
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.